No connection

Search Results

ABBV vs SENS

ABBV
AbbVie Inc.
NEUTRAL
Price
$219.26
Market Cap
$387.52B
Sector
Healthcare
AI Confidence
68%
SENS
Senseonics Holdings, Inc.
BEARISH
Price
$6.77
Market Cap
$283.0M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
ABBV
163.63
SENS
--
Forward P/E
ABBV
15.42
SENS
-2.57
P/B Ratio
ABBV
-146.66
SENS
4.58
P/S Ratio
ABBV
6.5
SENS
8.03
EV/EBITDA
ABBV
15.27
SENS
-3.44

Profitability

Gross Margin
ABBV
71.46%
SENS
44.71%
Operating Margin
ABBV
35.5%
SENS
-146.78%
Profit Margin
ABBV
4.0%
SENS
-196.03%
ROE
ABBV
137.96%
SENS
-168.27%
ROA
ABBV
9.59%
SENS
-37.68%

Growth

Revenue Growth
ABBV
9.1%
SENS
71.8%
Earnings Growth
ABBV
-88.7%
SENS
--

Financial Health

Debt/Equity
ABBV
--
SENS
0.68
Current Ratio
ABBV
0.72
SENS
4.83
Quick Ratio
ABBV
0.47
SENS
4.37

Dividends

Dividend Yield
ABBV
3.05%
SENS
--
Payout Ratio
ABBV
490.15%
SENS
0.0%

AI Verdict

ABBV NEUTRAL

The Advanced Deterministic Scorecard reveals a mixed health profile with a Piotroski F-Score of 4/9 indicating stable but not strong fundamentals, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite robust operating margins and consistent revenue growth, the company faces significant headwinds from negative earnings growth, an extremely high P/E ratio, and a dangerously elevated payout ratio. Strong historical price performance and analyst buy sentiment are counterbalanced by bearish insider activity and deteriorating profitability trends. The stock appears to trade at a substantial premium to its intrinsic value, suggesting limited margin of safety.

Strengths
High operating margin (35.50%) indicating strong pricing power and cost control
Consistent revenue growth (9.10% YoY) outpacing sector average
Strong track record of earnings surprises (22 out of 25 quarters beat estimates)
Risks
Extremely high P/E ratio (163.63) vs forward P/E (15.42), suggesting potential overvaluation on trailing basis
Earnings growth collapsing (YoY: -88.70%, Q/Q: -88.10%) indicating severe profitability deterioration
Unsustainable dividend payout ratio (490.15%) threatening dividend security
SENS BEARISH

SENS exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 1/9, indicating critical failures in profitability and operational efficiency. While the company shows impressive top-line revenue growth of 71.80% and maintains a strong liquidity position (Current Ratio 4.83), these are offset by a devastating profit margin of -196.03% and a consistent track record of missing earnings estimates. The stock is in a long-term bearish trend with a 5-year decline of 81.7%, suggesting that the market is discounting the growth in favor of the unsustainable burn rate.

Strengths
Strong YoY revenue growth of 71.80%
High liquidity with a Current Ratio of 4.83
Positive Gross Margin of 44.71% indicating product viability
Risks
Critical financial health (Piotroski F-Score 1/9)
Severe negative profitability (Profit Margin -196.03%)
Poor earnings track record with 0/4 beats in the last year

Compare Another Pair

ABBV vs SENS: Head-to-Head Comparison

This page compares AbbVie Inc. (ABBV) and Senseonics Holdings, Inc. (SENS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile